Dispersive solid phase extraction of metronidazole and clarithromycin from human plasma using a β-cyclodextrin grafted polyethylene polymer composite

In this work, for the first time, a polymeric composite based on β-cyclodextrin grafted with polyethylene has been prepared through ball milling and used as an efficient sorbent for dispersive solid phase extraction of metronidazole and clarithromycin from plasma samples. The prepared sorbent was characterized using Fourier transform infrared spectrophotometry, X-ray diffraction, and scanning electron microscopy. In the extraction process, after precipitating the proteins, the sorbent was added into the sample solution, and the mixture was vortexed to facilitate and speed up the sorption of the analytes onto the sorbent surface. After centrifuging, the sorbent particles were contacted with methanol to elute the analytes under the vortexing process. After this step, an aliquot of the eluate was taken and injected into high-performance liquid chromatography–diode array detector for quantitative analysis. Under the optimum extraction conditions, the extraction recoveries for metronidazole and clarithromycin were 76 and 83%, respectively. The limits of detection were 2.6 and 2.2 ng/ml for metronidazole and clarithromycin, respectively. The repeatability of the offered approach, expressed as relative standard deviation, was equal to or less than 4.7%. Finally, the method was successfully applied to plasma samples of the patients treated with metronidazole and clarithromycin.     

Use of liquid chromatography for separation and determination of carrier species associated with the synthesis of no carrier-added11C-labelled compounds determination of the specific activity of {11C} urea

An analytical technique using reversed-phase liquid chromatography has been developed for the determination of urea at quantities as low as 1 ng to quantitate the amount of non-labelled urea produced during the synthesis of no-carrier-added {¹¹C}urea starting from¹¹CN^–. As a result, the specific activity of the {¹¹C} urea thus prepared was calculated to be as high as 3.5±0.8 Ci/mol.Research supported in part by PHS Grant NINCDS 1 PO1 NS 15639.     

The Anticancer Activity and HSA Binding Properties of the Structurally Related Platinum (II) Complexes

The development of resistance and unwanted harmful interaction with other biomolecules instead of DNA are the major drawbacks for application of platinum (Pt) complexes in cancer chemotherapy. To conquer these problems, much works have been done so far to discover innovative Pt complexes. The objective of the current study was to evaluate the anti cancer activities of a series of four and five-coordinated Pt(II) complexes, having deprotonated 2-phenyl pyridine (abbreviated as C^N), biphosphine moieties, i.e., dppm?=?bis(diphenylphosphino) methane (Ph₂PCH₂PPh₂) and dppa?=?bis(diphenylphosphino)amine (Ph₂PNHPPh₂), as the non-leaving carrier groups. The growth inhibitory effect of the Pt complexes [Pt(C^N)(dppm)]PF₆: C ₁ , [Pt(C^N)(dppa)]PF₆: C ₂ , and [Pt(C^N)I(dppa)]: C ₃ , toward the cancer cell lines was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. In addition, the florescence quenching experiments of the interaction between human serum albumin (HSA) and the Pt complexes were performed in order to obtain the binding parameters and to evaluate the denaturing properties of these complexes upon binding to the general carrier protein of blood stream. The structure?Cactivity relationship studies reveal that four-coordinated Pt complexes C ₁ and C ₂ with both significant hydrophobic and charge characteristics, not only exhibit strong antiproliferation activity toward the cancer cell lines, but also they display lower denaturing effect against carrier protein HSA. On the other hand, five-coordinated C ₃ complex with the unusual intermolecular NH??Pt hydrogen binding and the intrinsic ability for oligomerization, exhibits poor anticancer activity and strong denaturing property. The current study reveals that the balance between charge and hydrophobicity of the Pt complexes, also their hydrogen binding abilities and coordination mode are important for their anticancer activities. Moreover, this study may suggest C ₁ and C ₂ as the potential template structures for synthesis of new generation of four-coordinated Pt complexes with strong anticancer activities and weak denaturing effects against proteins.     

A mononuclear, mixed (salicylato) (nicotinamide) complex of Zn(II) with penta- and hexa-coordination sites: a novel framework structure

The title compound, diaqua(bissalicylato-??O)(bisnicotinamide-??N)zinc(II)][bis(triaqua (monosalicylato-??O)(mononicotinamide-??N)zinc(II)salicylate, includes three Zn(II) ions, four nicotinamide ligands, six salicylate ligands and eight coordinated aqua ligands in the asymmetric unit in complex structure. The geometry around one of the Zn(II) ions is a slightly distorted octahedron, of which the equatorial plane is formed by two carboxylate oxygens and two aqua oxygens, while the axial positions are occupied by two pyridyl nitrogen atoms. The other Zn(II) ions adopt fivefold coordinations with one carboxylate oxygen atom from salicylate ligand, one N atom from nicotinamide ligand and three oxygen atoms from aqua ligands. In addition, there are two salicylate anions in the unit cell that are not coordinated. They provide charge balance as counter-ions in the complex framework.